Article info
PDFClinical guidelines
Myasthenia gravis: Association of British Neurologists’ management guidelines
- Correspondence to Dr Jon Sussman, Department of Neurology, Greater Manchester Neuroscience Centre, Stott Lane, Salford, Greater Manchester, M6 8HD, UK; Jon.sussman{at}manchester.ac.uk
Citation
Myasthenia gravis: Association of British Neurologists’ management guidelines
Publication history
- Accepted April 13, 2015
- First published May 14, 2015.
Online issue publication
December 20, 2016
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis
- Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan
- Update on myasthenia gravis
- Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment
- When the patient fails to respond to treatment: myasthenia gravis
- New and emerging treatments for myasthenia gravis
- Myasthenia gravis and other neuromuscular junction disorders
- Myasthenia and related disorders of the neuromuscular junction
- A case of diplopia and arm weakness
- THE NEUROMUSCULAR JUNCTION DISORDERS